The Dallas Foundation Chair in Gynecologic Oncology
Academic Title:
Professor
Primary Appointment:
Obstetrics and Gynecology
Secondary Appointment:
Simmons Comprehensive Cancer Center
School:
Southwestern Medical School
Affiliations:
Ob/Gyn Seay Biomedical Building Simmons Comprehensive Cancer Center The Harold C. Simmons Comprehensive Cancer Center The James W. Aston Clinical Building
Miller, D.S., Blessing, J.A., Bodurka, D.C., Bonebrake, A.J., Schorge, J.O., "Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group" Gynecologic Oncology, 110(1):65-70, July 2008
Bull Phelps, S.L., Schorge, J.O., Peyton, M.J., Shigematsu, H., Xiang, L.-L., Miller, D.S., Lea, J.S., "Implications of EGFR inhibition in ovarian cancer cell proliferation" Gynecologic Oncology, 109(3):411-7, June 2008
Bull-Phelps, S.L., Garner, E.I.O., Walsh, C.S., Gehrig, P.A., Miller, D.S., Schorge, J.O., "Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix" Gynecologic Oncology, 107 (2):316-319, November 2007
Knowles, L.M., Drake, R.D., Ashfaq, R., Castrillon, D.H., Miller, D.S., Schorge, J.O., "Simplifying the preevacuation testing strategy for patients with molar pregnancy" The Journal of reproductive medicine, 52 (8):685-688, August 2007
Lea, J.S., Sunaga, N., Sato, M., Kalahasti, G., Miller, D.S., Minna, J.D., Muller, C.Y., "Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells" Reproductive Sciences, 14 (1):20-28, 2007
SIGNIFICANT PUBLICATIONS
O’Boyle, J.D., Coleman, R.L., Bernstein, S.G., Lifshitz, S., Muller, C.Y., Miller, D.S., "Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study" Gynecologic Oncology, 79 (2):238-243, 2000
Thai TH, Du F, Tsan JT, Jin Y, Phung A, Spillman MA, Massa HF, Muller CY, Ashfaq R, Mathis JM, Miller DS, Trask BJ, Baer R, Bowcock AM., "Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers" Human Molecular Genetics, 7 (2):195-202, 1998
Moore DH. Blessing JA. McQuellon RP. Thaler HT. Cella D. Benda J. Miller DS. Olt G. King S. Boggess JF. Rocereto TF., "Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study" Journal of Clinical Oncology, 22(15):3113-9, August 2004
Long HJ 3rd. Bundy BN. Grendys EC Jr. Benda JA. McMeekin DS. Sorosky J. Miller DS. Eaton LA. Fiorica JV., "Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study" Journal of Clinical Oncology, 23(21):4626-33, July 2005
Bulun, S.E., Economos, K., Miller, D., Simpson, E.R., "CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors" Journal of Clinical Endocrinology and Metabolism, 79 (6):1831-1834, 1994
Point and right click (click and hold for Mac users) your mouse onand select "Save this link (or target) as..." option to save the file to your local computer.
